Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SPAG5 |
| Upstream (Parents) |
|---|
| (<<) CCNB1 → SPAG5 |
| (<<) CENPF → SPAG5 |
| (<<) CHAF1A → SPAG5 |
| (<<) DAB2 → SPAG5 |
| (<<) EBP → SPAG5 |
| (<<) EFEMP2 → SPAG5 |
| (<<) IGFBP4 → SPAG5 |
| (<<) IL1R1 → SPAG5 |
| (<<) MMP2 → SPAG5 |
| (<<) MYLK → SPAG5 |
| (<<) PDK1 → SPAG5 |
| (<<) PTPRE → SPAG5 |
| (<<) RHOB → SPAG5 |
| (<<) TCOF1 → SPAG5 |
| (<<) TRAF2 → SPAG5 |
| (<<) TXNIP → SPAG5 |
| (<<) ZNF554 → SPAG5 |
| Downstream (Children) |
|---|
| SPAG5 → AIFM1 (>>) |
| SPAG5 → BRCA1 (>>) |
| SPAG5 → CCNB2 (>>) |
| SPAG5 → CCND3 (>>) |
| SPAG5 → CCNE1 (>>) |
| SPAG5 → CPD (>>) |
| SPAG5 → CTSF (>>) |
| SPAG5 → DNM1L (>>) |
| SPAG5 → E2F1 (>>) |
| SPAG5 → E2F7 (>>) |
| SPAG5 → GLI3 (>>) |
| SPAG5 → GNAQ (>>) |
| SPAG5 → KLHL7 (>>) |
| SPAG5 → KRTAP4-1 (>>) |
| SPAG5 → LGALS3 (>>) |
| SPAG5 → LRP8 (>>) |
| SPAG5 → MTHFD2 (>>) |
| SPAG5 → MTRR (>>) |
| SPAG5 → N4BP3 (>>) |
| SPAG5 → NFIL3 (>>) |
| SPAG5 → NKD2 (>>) |
| SPAG5 → ORC6L (>>) |
| SPAG5 → ORM1 (>>) |
| SPAG5 → PABPC3 (>>) |
| SPAG5 → PDIA3 (>>) |
| SPAG5 → PLA2R1 (>>) |
| SPAG5 → POP1 (>>) |
| SPAG5 → PRDX6 (>>) |
| SPAG5 → RFFL (>>) |
| SPAG5 → RND3 (>>) |
| SPAG5 → RPL23A (>>) |
| SPAG5 → SLC25A25 (>>) |
| SPAG5 → SLC25A32 (>>) |
| SPAG5 → SYNPO (>>) |
| SPAG5 → UBE2C (>>) |
| SPAG5 → YRDC (>>) |
